{
    "2021-04-22": [
        [
            {
                "time": "",
                "original_text": "安图生物今日大宗交易成交2.19万股，成交价124.1元溢价0.0%",
                "features": {
                    "keywords": [
                        "安图生物",
                        "大宗交易",
                        "成交价",
                        "溢价"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "安图生物(603658.SH)一季度净利润升84.15%至1.71亿元",
                "features": {
                    "keywords": [
                        "安图生物",
                        "一季度",
                        "净利润",
                        "增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "安图生物(603658.SH)年度归母净利同比下降3.41%至7.48亿元 每10股转增3股派8.5元 盈利能力下降",
                "features": {
                    "keywords": [
                        "安图生物",
                        "年度",
                        "归母净利",
                        "下降",
                        "分红"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "安图生物(603658.SH)2020年度净利润降3.41%至7.48亿元拟10转3派8.5元 盈利能力下降",
                "features": {
                    "keywords": [
                        "安图生物",
                        "2020年度",
                        "净利润",
                        "下降",
                        "分红"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "安图生物(603658.SH)一季度归母净利同比增长84.15%至1.71亿元",
                "features": {
                    "keywords": [
                        "安图生物",
                        "一季度",
                        "归母净利",
                        "增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "安图生物：预计为全资子公司提供不超过3亿元担保 大额借贷担保",
                "features": {
                    "keywords": [
                        "安图生物",
                        "子公司",
                        "担保",
                        "借贷"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "安图生物：2020年净利润同比减少3.41% 盈利能力下降",
                "features": {
                    "keywords": [
                        "安图生物",
                        "2020年",
                        "净利润",
                        "减少",
                        "盈利能力"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "安图生物：一季度净利润同比增长84.15%",
                "features": {
                    "keywords": [
                        "安图生物",
                        "一季度",
                        "净利润",
                        "增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医疗器械股整体活跃，伟思医疗涨近13%",
                "features": {
                    "keywords": [
                        "医疗器械",
                        "伟思医疗",
                        "活跃",
                        "上涨"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}